Onychomycosis: therapeutic update (Q33657958)

28 July 2017

1 reference

title

Onychomycosis: therapeutic update (English)

1 reference

28 July 2017

Scher RK

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Journal of the American Academy of Dermatology

28 July 2017

published in

1 reference

28 July 2017

volume

40

1 reference

28 July 2017

issue

6 Pt 2

1 reference

28 July 2017

page(s)

S21-6

1 reference

Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Once-weekly fluconazole in the treatment of onychomycosis: introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Onychomycosis is more than a cosmetic problem

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Quality of life of persons with onychomycosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Effect of onychomycosis on quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Current management of onychomycosis. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Kinetics and spectrum of activity of oral antifungals: the therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Onychomycosis. Agents of choice.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

Fluconazole in the treatment of severe onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970397-X

7 January 2021

10.1016/S0190-9622(99)70397-X

Identifiers

DOI

0 references

1 reference